- Activity pressure is positive on the latest completed week.
CRI
PAR
Week ended 07 Aug 2026
Weekly Investor Report
Compagnie Chargeurs Invest · Industrials · Conglomerates
Latest close
8.40 EUR
-0.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -1.5% below the Trend Line and sits at 33.6% of its 52-week range. The latest completed week returned -0.5%, after a -7.7% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
31
out of 100
Latest Close
8.40 EUR
7 Aug 2026
1W Return
-0.5%
latest completed week
4W Return
-7.7%
short-term follow-through
12W Return
20.1%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 40.72% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.5%
Latest completed week; four-week move -7.7%.
Indicator stack
0/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 40.72%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -1.5% below the Trend Line and sits at 33.6% of its 52-week range. The latest completed week returned -0.5%, after a -7.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2512-week average 0.10
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.25Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -7.7% over four weeks, 20.1% over 12 weeks, and -22.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.88Latest activity-pressure read.
Pressure change572.6%Four-week change in activity pressure.
Leadership-16.09Latest relative-leadership reading.
RS change-111.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 5 relevant articles.
0 positive · 5 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-28.1%Distance below the 52-week high.
13-week volatility7.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher6 of 2620 weeks finished lower.
Best week+19.0%Week of 10 Jul.
Worst week-19.0%Week of 24 Apr.
Latest week-0.5%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains4
Flat weeks0
Modest losses17
Sharp losses3
Recent vol7.3%13-week weekly-return volatility.
Base vol5.3%52-week weekly-return volatility.
Up/down split15/35Count of positive and negative weeks in the 52-week window.
Average skew4.7% / -2.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Industrials
4-week rank92 / 98
Group average3.2%
Trend breadth48.0%
Trend48.0%active weekly trend signals
MD57.1%positive activity pressure
RS45.9%positive relative leadership
Four-week leaders
IndustryFR Conglomerates
4-week rank3 / 3
Group average-3.2%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD33.3%positive activity pressure
RS33.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis22/100Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.
Activity pressure 0.25; No reversal markers Next-Week ExpectancyNegative 40.72%Next-week expectancy is negative with a 40.72% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 5 relevant articles.
DC Advisory advises Compagnie Chargeurs Invest on the sale of Novacel to KPS Capital Partners Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 8.40 EUR | -0.5% | 8.52 EUR | 10.21 EUR | 0.88 | -16.09 | 38.9K | Off |
| 31 Jul 2026 | 8.44 EUR | -2.9% | 8.59 EUR | 10.22 EUR | 1.00 | -14.29 | 27.2K | Off |
| 24 Jul 2026 | 8.69 EUR | -4.0% | 8.64 EUR | 10.24 EUR | 0.83 | -11.01 | 56.9K | Off |
| 17 Jul 2026 | 9.05 EUR | -0.5% | 8.69 EUR | 10.25 EUR | 0.70 | -7.64 | 19.5K | Off |
| 10 Jul 2026 | 9.10 EUR | 19.0% | 8.72 EUR | 10.27 EUR | 0.13 | -7.60 | 287.8K | Off |
| 3 Jul 2026 | 7.65 EUR | -3.8% | 8.74 EUR | 10.28 EUR | -0.55 | -24.23 | 9.6K | Off |
| 26 Jun 2026 | 7.95 EUR | 17.7% | 8.83 EUR | 10.29 EUR | -0.94 | -20.72 | 31.3K | Off |
| 19 Jun 2026 | 6.75 EUR | -1.4% | 8.91 EUR | 10.31 EUR | -1.37 | -33.36 | 1.0K | Off |
| 12 Jun 2026 | 6.85 EUR | -0.2% | 9.00 EUR | 10.34 EUR | -1.35 | -32.42 | 3.5K | Off |
| 5 Jun 2026 | 6.87 EUR | -1.4% | 9.10 EUR | 10.37 EUR | -1.34 | -31.75 | 5.4K | Off |
| 29 May 2026 | 6.97 EUR | 0.2% | 9.19 EUR | 10.41 EUR | -1.28 | -31.09 | 31.6K | Off |
| 22 May 2026 | 6.95 EUR | -0.6% | 9.28 EUR | 10.44 EUR | -1.34 | -31.25 | 39.4K | Off |
| 15 May 2026 | 6.99 EUR | -1.7% | 9.39 EUR | 10.48 EUR | -1.45 | -30.09 | 32.1K | Off |
| 8 May 2026 | 7.11 EUR | 3.1% | 9.51 EUR | 10.52 EUR | -1.36 | -30.90 | 47.1K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.